WDB HOLDINGS CO., LTD.
2475・Prime Market・Services
Business
WDB Holdings was founded in 1985 and operates as a pure holding company overseeing 14 subsidiaries as a specialized staffing services group. Its core staffing services business focuses on registered-type and permanent-employment-type staffing and placement services for personnel in bio/chemistry research roles (science field) and machinery/electrical/software engineering roles (engineering field). In science-field research staffing, the company boasts a strong market presence, with "1 in 3 people working in dispatched research positions employed through the WDB Group." In the CRO business, the company handles safety information management primarily in Japan, while undertaking overall development operations overseas (through entities such as Medifiles in Finland). Consolidated net sales for FY2026 (ending March 2026) were ¥50,305 million, with the staffing services business accounting for 86.6% of sales.
Business Model
In the staffing services business, the company hires science and engineering specialist personnel as its own employees and dispatches them to client companies, generating profit from the spread between staffing fees and personnel costs. The structure of passing on staff salary increase costs through fee renegotiations supports profit margins. In the CRO business, the company undertakes development work commissioned by pharmaceutical and medical device manufacturers and earns service provision fees. In both businesses, securing and retaining personnel is fundamental to revenue, and digitalization through platforms such as "Doko-1" aims to reduce intermediary costs and expand customer acquisition channels.
Company Strengths
According to the securities report, one in three people working in dispatched scientific research positions is employed through the WDB Group, establishing an overwhelming market presence in this field. In FY2026 (ending March 2026), sales in the scientific research field reached ¥34,305 million, accounting for 78.8% of the total staffing services business. The depth of the customer base and staff base built through years of specialization makes it difficult for competitors to imitate.
In FY2026 (ending March 2026), the company absorbed wage increase costs for dispatched staff by raising placement fees, improving the staffing services segment's operating margin from 9.4% in the previous period to 9.9%. In an environment where rising wages are squeezing industry-wide profit margins, this result demonstrates the strong pricing power gained through specialization in professional fields.
Since 2016, the company has promoted its transformation into a platform operator, developing and operating in-house the staffing service platforms "doconico" and "Doko1," as well as the CRO service platform "CoCopos." "Doko1," launched in May 2025, enables simultaneous ordering and centralized management across multiple staffing agencies, and the number of contracts has been steadily increasing. Nezotto Corporation handles development, operation, and maintenance, forming an in-house structure.
ENVALITH's Perspective
Performance Trend
Revenue expanded from ¥46,876 million in FY2022 to ¥51,137 million in FY2025, but FY2026 saw the first decline, at ¥50,304 million (down 1.6% year on year). Operating profit peaked at ¥6,314 million in FY2022 and has declined for four consecutive periods, reaching ¥4,464 million in FY2026 (down 11.9% year on year). The operating margin has continued to fall, from 13.5% in FY2022 to 8.9% in FY2026. On the external environment side, the effective job openings-to-applicants ratio stood at 1.20 (down 0.05 points year on year), and labor shortages persist, but rising costs to secure job seekers (improved treatment for dispatched staff) and expanding SG&A expenses have squeezed profits. ROE also declined, from 9.9% to 8.5%. Operating cash flow fell sharply to ¥2,793 million (from ¥4,367 million in the prior period), affected by an increase of ¥1,837 million in corporate tax payments.
Growth Strategy
Two pillars: maximizing value as a staffing company and transforming into a platform operating company
The company has continued to improve treatment of temporary staff since April 2022 and will continue to do so going forward. In FY2026 (ending March 2026), it absorbed wage increases through staffing fee hikes, improving the segment profit margin of the staffing services business to 9.9%. Both order acceptance rates and turnover rates have been confirmed to be improving.
"Doko1," launched in May 2025, is a platform that enables batch ordering and centralized management across multiple staffing companies. Through active sales activities, the number of contracts is steadily increasing. To further expand the business, the company is also developing multiple new platforms in parallel, aiming to expand its customer base through digital channels.
Amid the challenge of securing job seekers to meet demand, since April 2025 the company has been promoting the hiring of senior workers, those seeking part-time work, and region-limited regular-employee-type temporary staff. This initiative aims to boost supply capacity by capturing diverse work styles and is contributing to improved order acceptance rates for staffing requests.
Domestically, the company is promoting automation and standardization of outsourced business processes (creation of automation tool prototypes) and efficiency improvements through the introduction of AI-assisted document creation tools. Overseas, at MedFiles, the divestiture of unprofitable businesses has been completed, and the company aims to improve profit margins and increase order volume by focusing on four areas: regulatory affairs applications, clinical trials, DM statistical analysis, and safety evaluation.
Last updated: July 19, 2026